SEED Therapeutics Inc.

About SEED Therapeutics Inc.

SEED Therapeutics, Inc. is dedicated to breaking through scientific barriers to discover Molecular Glues for effective therapies and cures for debilitating diseases and disorders. They partner with world-leading experts in the Ubiquitin Proteasome System and Targeted Protein Degradation to advance their groundbreaking discovery platform targeting multiple indications including cancer, neurodegeneration, and infectious diseases.

Products & Services

Molecular Glues Discovery Platform:A platform for discovering Molecular Glues aimed at treating various indications such as cancer, neurodegeneration, and infectious diseases.

Specialties

Molecular Glues Ubiquitin Proteasome System Targeted Protein Degradation Cancer Treatment Neurodegeneration Treatment Infectious Diseases Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A-3 T: - FT: Series A-3	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2025-09-23 FD: 2025-09-23	2 investors

Series A-3 Latest

2025-09-23

$30.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Avram Hershko

Co-Founder and SAB Member

N

Ning Zheng

Co-Founder and SAB Member

M

Michele Pagano

Co-Founder and SAB Member

L

Lan Huang

Co-Founder, CEO and Chairman

J

James Tonra

President, CSO and Director

B

Bill Desmarais

Chief Financial Officer and Chief Business Officer

View 31 more team members with Pro

Unlock Full Team Directory

Recent News